ResearcherKyushu UniversityActive in the last 2 years
Nobuhiro Fujita
Matched on ORCID iD 0000-0001-9708-050X; OpenAlex author ID A5002294470. Sources: OpenAlex.
Their work
- Papers
- 6
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 28
2023: 3 papers · 2024: none · 2025: 2 papers · 2026: 1 paper
Papers 6
- Characteristics of ill-demarcated small pancreatic ductal adenocarcinoma on MRI: a multi-institutional retrospective cohort study. Co-author DOI 10.1007/s11604-026-02003-8↗
- Prognostic Significance of Desmoplastic Reaction Classification and Its Association With Stromal Biomarkers in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1016/j.modpat.2025.100865↗
- Clinical efficacy of pancreas-preserving distal pancreatectomy for the treatment of pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.surg.2024.108958↗
- Clinical Implications of FDG-PET in Pancreatic Ductal Adenocarcinoma Patients Treated with Neoadjuvant Therapy. Co-author DOI 10.1007/s11605-023-05591-2↗
- Extracellular volume fraction determined by dual-layer spectral detector CT: Possible role in predicting the efficacy of preoperative neoadjuvant chemotherapy … Co-author DOI 10.1016/j.ejrad.2023.110756↗
- Prognostic Impact of Preoperative Osteosarcopenia for Patients with Pancreatic Ductal Adenocarcinoma After Curative Resection. Co-author DOI 10.1245/s10434-023-13936-z↗
Closest collaborators
The 25 strongest of 28 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Kousei Ishigami · 5 shared papers, 2023–2025 · strength 0.97
- Paper Prognostic Significance of Desmoplastic Reaction Classification and Its Association With Stromal Biomarkers in Pancreat… DOI 10.1016/j.modpat.2025.100865↗
- Paper Clinical efficacy of pancreas-preserving distal pancreatectomy for the treatment of pancreatic ductal adenocarcinoma. DOI 10.1016/j.surg.2024.108958↗
- Paper Prognostic Impact of Preoperative Osteosarcopenia for Patients with Pancreatic Ductal Adenocarcinoma After Curative Res… DOI 10.1245/s10434-023-13936-z↗
- Kohei Nakata · 5 shared papers, 2023–2025 · strength 0.97
- Paper Prognostic Significance of Desmoplastic Reaction Classification and Its Association With Stromal Biomarkers in Pancreat… DOI 10.1016/j.modpat.2025.100865↗
- Paper Clinical efficacy of pancreas-preserving distal pancreatectomy for the treatment of pancreatic ductal adenocarcinoma. DOI 10.1016/j.surg.2024.108958↗
- Paper Prognostic Impact of Preoperative Osteosarcopenia for Patients with Pancreatic Ductal Adenocarcinoma After Curative Res… DOI 10.1245/s10434-023-13936-z↗
- Masafumi Nakamura · 3 shared papers, 2023–2025 · strength 0.57
- Paper Clinical efficacy of pancreas-preserving distal pancreatectomy for the treatment of pancreatic ductal adenocarcinoma. DOI 10.1016/j.surg.2024.108958↗
- Paper Prognostic Impact of Preoperative Osteosarcopenia for Patients with Pancreatic Ductal Adenocarcinoma After Curative Res… DOI 10.1245/s10434-023-13936-z↗
- Paper Extracellular volume fraction determined by dual-layer spectral detector CT: Possible role in predicting the efficacy o… DOI 10.1016/j.ejrad.2023.110756↗
- Toshiya Abe · 3 shared papers, 2023–2025 · strength 0.57
- Paper Clinical efficacy of pancreas-preserving distal pancreatectomy for the treatment of pancreatic ductal adenocarcinoma. DOI 10.1016/j.surg.2024.108958↗
- Paper Prognostic Impact of Preoperative Osteosarcopenia for Patients with Pancreatic Ductal Adenocarcinoma After Curative Res… DOI 10.1245/s10434-023-13936-z↗
- Paper Clinical Implications of FDG-PET in Pancreatic Ductal Adenocarcinoma Patients Treated with Neoadjuvant Therapy. DOI 10.1007/s11605-023-05591-2↗
- Noboru Ideno · 3 shared papers, 2023–2025 · strength 0.57
- Paper Clinical efficacy of pancreas-preserving distal pancreatectomy for the treatment of pancreatic ductal adenocarcinoma. DOI 10.1016/j.surg.2024.108958↗
- Paper Prognostic Impact of Preoperative Osteosarcopenia for Patients with Pancreatic Ductal Adenocarcinoma After Curative Res… DOI 10.1245/s10434-023-13936-z↗
- Paper Clinical Implications of FDG-PET in Pancreatic Ductal Adenocarcinoma Patients Treated with Neoadjuvant Therapy. DOI 10.1007/s11605-023-05591-2↗
- Naoki Ikenaga · 3 shared papers, 2023–2025 · strength 0.57
- Paper Clinical efficacy of pancreas-preserving distal pancreatectomy for the treatment of pancreatic ductal adenocarcinoma. DOI 10.1016/j.surg.2024.108958↗
- Paper Prognostic Impact of Preoperative Osteosarcopenia for Patients with Pancreatic Ductal Adenocarcinoma After Curative Res… DOI 10.1245/s10434-023-13936-z↗
- Paper Clinical Implications of FDG-PET in Pancreatic Ductal Adenocarcinoma Patients Treated with Neoadjuvant Therapy. DOI 10.1007/s11605-023-05591-2↗
- Yoshinao Oda · 3 shared papers, 2023–2025 · strength 0.55
- Paper Prognostic Significance of Desmoplastic Reaction Classification and Its Association With Stromal Biomarkers in Pancreat… DOI 10.1016/j.modpat.2025.100865↗
- Paper Clinical Implications of FDG-PET in Pancreatic Ductal Adenocarcinoma Patients Treated with Neoadjuvant Therapy. DOI 10.1007/s11605-023-05591-2↗
- Paper Extracellular volume fraction determined by dual-layer spectral detector CT: Possible role in predicting the efficacy o… DOI 10.1016/j.ejrad.2023.110756↗
- Nao Fujimori · 3 shared papers, 2023–2025 · strength 0.54
- Paper Clinical efficacy of pancreas-preserving distal pancreatectomy for the treatment of pancreatic ductal adenocarcinoma. DOI 10.1016/j.surg.2024.108958↗
- Paper Clinical Implications of FDG-PET in Pancreatic Ductal Adenocarcinoma Patients Treated with Neoadjuvant Therapy. DOI 10.1007/s11605-023-05591-2↗
- Paper Extracellular volume fraction determined by dual-layer spectral detector CT: Possible role in predicting the efficacy o… DOI 10.1016/j.ejrad.2023.110756↗
- Masatoshi Murakami · 2 shared papers, 2023–2025 · strength 0.39
- Paper Clinical efficacy of pancreas-preserving distal pancreatectomy for the treatment of pancreatic ductal adenocarcinoma. DOI 10.1016/j.surg.2024.108958↗
- Paper Clinical Implications of FDG-PET in Pancreatic Ductal Adenocarcinoma Patients Treated with Neoadjuvant Therapy. DOI 10.1007/s11605-023-05591-2↗
- So Nakamura · 2 shared papers, 2023 · strength 0.34
- Paper Prognostic Impact of Preoperative Osteosarcopenia for Patients with Pancreatic Ductal Adenocarcinoma After Curative Res… DOI 10.1245/s10434-023-13936-z↗
- Paper Clinical Implications of FDG-PET in Pancreatic Ductal Adenocarcinoma Patients Treated with Neoadjuvant Therapy. DOI 10.1007/s11605-023-05591-2↗
- Keitaro Sofue · 1 shared paper, 2026 · strength 0.26
- Yoshihiko Fukukura · 1 shared paper, 2026 · strength 0.26
- Yoshiki Asayama · 1 shared paper, 2026 · strength 0.26
- Dai Inoue · 1 shared paper, 2026 · strength 0.26
- Yoshifumi Noda · 1 shared paper, 2026 · strength 0.26
- Shogo Takeuchi · 1 shared paper, 2026 · strength 0.26
- Satoshi Goshima · 1 shared paper, 2026 · strength 0.26
- Shoko Noguchi · 1 shared paper, 2025 · strength 0.24
- Takashi Matsumoto · 1 shared paper, 2025 · strength 0.24
- Koji Shindo · 1 shared paper, 2025 · strength 0.24
- Masafumi Nakamura · 1 shared paper, 2025 · strength 0.24
- Yusuke Watanabe · 1 shared paper, 2025 · strength 0.23
- Yoshihiro Ogawa · 1 shared paper, 2025 · strength 0.23
- Kazuyoshi Nishihara · 1 shared paper, 2023 · strength 0.18
- Masataka Hayashi · 1 shared paper, 2023 · strength 0.16
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.